A review of current and pipeline drugs for treatment of melanoma
N Natarelli, SJ Aleman, IM Mark, JT Tran, S Kwak… - Pharmaceuticals, 2024 - mdpi.com
Malignant melanoma is the most aggressive form of skin cancer. Standard treatment options
include surgery, radiation therapy, systemic chemotherapy, targeted therapy, and …
include surgery, radiation therapy, systemic chemotherapy, targeted therapy, and …
Melanoma treatments and mortality rate trends in the US, 1975 to 2019
Importance Melanoma accounts for most of the deaths due to skin cancer. In the past
decade, effective US Food and Drug Administration (FDA)–approved therapies for …
decade, effective US Food and Drug Administration (FDA)–approved therapies for …
NCCN guidelines® insights: Melanoma: Cutaneous, version 2.2024: Featured updates to the NCCN guidelines
SM Swetter, D Johnson, MR Albertini… - Journal of the National …, 2024 - jnccn.org
The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide
multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients …
multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients …
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
P Kozyra, D Krasowska, M Pitucha - International Journal of Molecular …, 2022 - mdpi.com
Malignant melanoma (MM) is the most lethal skin cancer. Despite a 4% reduction in mortality
over the past few years, an increasing number of new diagnosed cases appear each year …
over the past few years, an increasing number of new diagnosed cases appear each year …
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
E Sosa Cuevas, J Valladeau-Guilemond… - Frontiers in …, 2022 - frontiersin.org
Subversion of immunity by tumors is a crucial step for their development. Dendritic cells
(DCs) are strategic immune cells that orchestrate anti-tumor immune responses but display …
(DCs) are strategic immune cells that orchestrate anti-tumor immune responses but display …
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
ABSTRACT Indoleamine 2, 3 dioxygenase 1 (IDO1), a leader tryptophan-degrading
enzyme, represents a recognized immune checkpoint molecule. In neoplasia, IDO1 is often …
enzyme, represents a recognized immune checkpoint molecule. In neoplasia, IDO1 is often …
Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis
S Zheng, H Yu, X Zheng, UT Wu, W Ming… - Frontiers in …, 2023 - frontiersin.org
Background The survival and prognosis of patients are significantly threatened by
cutaneous melanoma (CM), which is a highly aggressive disease. It is therefore crucial to …
cutaneous melanoma (CM), which is a highly aggressive disease. It is therefore crucial to …
Impact of anesthesia choice in cutaneous melanoma surgery
MGK Benesch, JJ Skitzki - Melanoma Research, 2024 - journals.lww.com
Invasive cutaneous melanoma is the most lethal skin cancer, but fortunately, the vast
majority can be surgically treated with wide local excision, and sometimes additionally with …
majority can be surgically treated with wide local excision, and sometimes additionally with …
Novel phenoxyacetylthiosemicarbazide derivatives as novel ligands in cancer diseases
P Kozyra, G Adamczuk, Z Karczmarzyk… - Toxicology and Applied …, 2023 - Elsevier
Numerous epidemiological studies report an increased risk of developing prostate cancer in
patients with melanoma and an increased risk of developing melanoma in patients with …
patients with melanoma and an increased risk of developing melanoma in patients with …
FDUM-Net: An enhanced FPN and U-Net architecture for skin lesion segmentation
Early detection is essential for the successful removal of all malignant lesions from the body,
and skin cancer is one of the most widespread cancers globally. In medical image analysis …
and skin cancer is one of the most widespread cancers globally. In medical image analysis …